SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001197
Filing Date
2024-02-15
Accepted
2024-02-15 07:05:16
Documents
15
Period of Report
2024-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20240215x8k.htm   iXBRL 8-K 36936
2 EX-99.1 bpmc-20240215xex99d1.htm EX-99.1 137846
  Complete submission text file 0001558370-24-001197.txt   304664

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20240215.xsd EX-101.SCH 3164
4 EX-101.LAB bpmc-20240215_lab.xml EX-101.LAB 15242
5 EX-101.PRE bpmc-20240215_pre.xml EX-101.PRE 9841
16 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20240215x8k_htm.xml XML 4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 24642028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)